Study Shows Ways to Turn Investments Into Maximum Outcomes in the Nuclear Medicine Radiopharmaceuticals Market
Global Nuclear Medicine Radiopharmaceuticals Market is estimated at $4500 million in 2015 and is expected to reach $8440 million by 2020, growing at a CAGR of 13.4%. Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.
View full press release